When naive mice were inoculated with tumor cells, the therapeutic effect of CXCL1/IFN-γ/sTNF-α was attenuated by depleting NK cells, but recovered by administrating NK cells (Figure 6A). This evidence concerns the gene CXCL1 and neoplasm.